Meheissen M A, Hendawy S M, Shabaan F S, Elmenshawy A M, Harfoush R A
Epidemiol Mikrobiol Imunol. 2022 Summer;71(2):86-92.
Colistin resistance poses a serious clinical problem. This study aims to investigate the presence of plasmid-mediated resistance and heteroresistance among Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae) clinical isolates at intensive care units of Main Alexandria University Hospital.
Seventy colistin-resistant and 30 colistin-susceptible K. pneumoniae and E. coli isolates constituted the material of the study. The rapid polymyxin NP (Nordmann Poirel) test was performed. Heteroresistance in colistin-susceptible isolates was investigated by population analysis profile. mcr-1 and mcr-2 genes were amplified by polymerase chain reaction (PCR).
The rapid polymyxin NP test showed 100% concordance with the results of BMD (broth microdilution method). Heteroresistance to colistin was detected in 23.3% of colistin-susceptible K. pneumoniae isolates. All colistin-resistant isolates were negative for mcr-1 and mcr-2 genes.
The rapid polymyxin NP test is a reliable screening tool for colistin resistance, but not for heteroresistance. Other colistin resistance mechanisms should be investigated.
黏菌素耐药性构成了一个严重的临床问题。本研究旨在调查亚历山大大学主医院重症监护病房中大肠埃希菌(E. coli)和肺炎克雷伯菌(K. pneumoniae)临床分离株中质粒介导的耐药性和异质性耐药的存在情况。
70株对黏菌素耐药以及30株对黏菌素敏感的肺炎克雷伯菌和大肠埃希菌分离株构成了研究材料。进行了快速多黏菌素NP(诺德曼-普雷尔)试验。通过群体分析谱研究了对黏菌素敏感分离株中的异质性耐药情况。通过聚合酶链反应(PCR)扩增mcr-1和mcr-2基因。
快速多黏菌素NP试验结果与肉汤微量稀释法(BMD)的结果显示100%一致。在23.3%的对黏菌素敏感的肺炎克雷伯菌分离株中检测到对黏菌素的异质性耐药。所有对黏菌素耐药的分离株mcr-1和mcr-2基因均为阴性。
快速多黏菌素NP试验是一种用于检测黏菌素耐药性的可靠筛选工具,但不适用于检测异质性耐药。应研究其他黏菌素耐药机制。